http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015223099-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cebc9740ef706cde29e885504f274ffa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69b4de7d64ebafc368b849bca94eab18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c61fa7f1813066bfcf14d7ef28d19c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b93fbc63ccf336ff4f707529dd82b23 |
| publicationDate | 2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015223099-A |
| titleOfInvention | Evaluation method of drug toxicity |
| abstract | An object of the present invention is to provide a method for evaluating drug toxicity, etc., which can be objectively evaluated quickly and at low cost without conducting administration tests on individual animals such as animal experiments. [MEANS FOR SOLVING PROBLEMS] The present invention uses a gene expression variation profile caused by exposing TGF-β1 to human cells as an index, and a gene caused by exposing a test target drug to human cells of the same type as the cells. This is a method for evaluating the toxicity of the test target drug to the human cells based on the results obtained by comparative analysis of the expression variation profile and the index. [Selection figure] None |
| priorityDate | 2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.